课题基金 / 基金详情

Chemical Biology and Drug Discovery of Cell Death

Chemical Biology and Drug Discovery of Cell Death
细胞死亡的化学生物学和药物发现
批准号:
nhmrc : 1117089
负责人:
A/Pr Guillaume Lessene
金额:
$48.17万
依托单位国家:
澳大利亚
项目类别:
Research Fellowships
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2021-12-31

项目摘要

项目成果

A/Pr Guillaume Lessene的其他基金

相似基金

相关文献

中文摘要
翻译
细胞程序性死亡调节细胞在发育和成年期的命运。在生物学和化学的前沿工作,我领导的研究项目致力于揭示细胞死亡过程涉及广泛的疾病,如癌症,炎症性疾病和组织损伤。我将开发新的小分子,作为强大的工具来增加我们对细胞死亡如何参与这些疾病的理解,并帮助开发新的药物来治疗它们。
英文摘要
Programmed cell death regulates the fate of cells during development and adult life. Working at the frontier of biology and chemistry, I lead research programs committed to uncovering cell death processes implicated in a wide range of diseases such as cancer, inflammatory diseases and tissue damage. I will develop novel small molecules that will act as powerful tools to increase our understanding of how cell death participates in these conditions and help develop new drugs to treat them.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Apoptosis and Stem/Progenitor Cells in the Development and Treatment of Cancer
Chemical Biology and Drug Discovery of Cell Death
  • 批准号:
    nhmrc : GNT1117089
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $70.64万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Guillaume Lessene
  • 依托单位:
Apoptosis and Stem/Progenitor Cells in the Development and Treatment of Cancer
  • 批准号:
    nhmrc : GNT1113133
  • 项目类别:
    Programs
  • 资助金额:
    $2180.96万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Guillaume Lessene
  • 依托单位:
Small molecule apoptosis inhibitors to define the Bak activating switch
国内基金
海外基金
Journal of Integrative Plant Biology
  • 批准号:
    31024801
  • 项目类别:
    专项基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2010
  • 负责人:
    贺萍
  • 依托单位: